SCHEMBL13701694

SCHEMBL13701694

COc1cccc(-c2cccc(C(=O)NC(C)(C)C)c2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT6A Q92794 1/20 0.56
▸ MEN1 O00255 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ POLB P06746 1/20 0.56
▸ MAPK1 P28482 1/20 0.54
▸ NPC1 O15118 2/20 0.54
▸ RAB9A P51151 2/20 0.54
▸ HSD17B2 P37059 1/20 0.53
▸ ANO1 Q5XXA6 1/20 0.53
▸ RXFP1 Q9HBX9 1/20 0.52
▸ PLAU P00749 2/20 0.52
▸ PLG P00747 1/20 0.52
▸ PLAT P00750 1/20 0.52
▸ FABP1 P07148 1/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ TP53 P04637 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ HDAC2 Q92769 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8541406 0.91 NPC1 (0.64) MEN1KMT2AMAPK1NPC1RAB9A
SCHEMBL13701659 0.85 PLAU (0.56) RAB9AANO1PLAUPLGPLAT
SCHEMBL3871458 0.83 NPC1 (0.55) KAT6AMEN1KMT2ANPC1RAB9A
SCHEMBL13701695 0.83 HDAC8 (0.64) KAT6APOLBANO1SMN1; SMN2LMNA
SCHEMBL13701654 0.81 RXRA (0.59) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL13701631 0.81 HDAC8 (0.54) KMT2ANPC1RAB9AALDH1A1LMNA
SCHEMBL13701672 0.80 PLAU (0.48) PLAUPLATLMNA
SCHEMBL13701677 0.80 KDM4E (0.50) MEN1KMT2ANPC1RAB9AHSD17B2
SCHEMBL6432447 0.80 NEK1 (0.63) KAT6AMEN1KMT2APOLBMAPK1
SCHEMBL13701634 0.79 MEN1 (0.58) MEN1KMT2APOLBMAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors FLECK ROMAN WOLFGANG 2009-09-10 — — US disclosed
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors FLECK ROMAN WOLFGANG 2009-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors EPHX1, EPHX2, EPX KAT6A 3567/4885MEN1 4409/4885KMT2A 3792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback